Literature DB >> 8151758

Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging.

D W Lazinski1, J M Taylor.   

Abstract

The hepatitis delta virus (HDV) genome is a circular, single-stranded, rod-shaped, 1.7-kb RNA that replicates via a rolling-circle mechanism. Viral ribozymes function to cleave replication intermediates which are then ligated to generate the circular product. HDV expresses two forms of a single protein, the small and large delta antigens (delta Ag-S and delta Ag-L), which associate with viral RNA in a ribonucleoprotein (RNP) structure. While delta Ag-S is required for RNA replication, delta Ag-L inhibits this process but promotes the assembly of the RNP into mature virions. In this study, we have expressed full-length and deleted HDV RNA inside cells to determine the minimal RNA sequences required for self-cleavage, ligation, RNP packaging, and virion assembly and to assess the role of either delta antigen in each of these processes. We report the following findings. (i) The cleavage and ligation reactions did not require either delta antigen and were not inhibited in their presence. (ii) delta Ag-L, in the absence of delta Ag-S, formed an RNP with HDV RNA which could be assembled into secreted virus-like particles. (iii) Full-length HDV RNAs were stabilized in the presence of either delta antigen and accumulated to much higher levels than in their absence. (iv) As few as 348 nucleotides of HDV RNA were competent for circle formation, RNP assembly, and incorporation into virus-like particles. (v) An HDV RNA incapable of folding into the rod-like structure was not packaged by delta Ag-L.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151758      PMCID: PMC236776     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Editing on the genomic RNA of human hepatitis delta virus.

Authors:  H Zheng; T B Fu; D Lazinski; J Taylor
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Cell-free circularization of viroid progeny RNA by an RNA ligase from wheat germ.

Authors:  A D Branch; H D Robertson; C Greer; P Gegenheimer; C Peebles; J Abelson
Journal:  Science       Date:  1982-09-17       Impact factor: 47.728

3.  Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications.

Authors:  M Y Kuo; J Goldberg; L Coates; W Mason; J Gerin; J Taylor
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Self-ligating RNA sequences on the antigenome of human hepatitis delta virus.

Authors:  L Sharmeen; M Y Kuo; J Taylor
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 5.  Recent developments in hepatitis delta virus research.

Authors:  D W Lazinski; J M Taylor
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

6.  Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA.

Authors:  J H Lin; M F Chang; S C Baker; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Ribonucleoprotein complexes of hepatitis delta virus.

Authors:  W S Ryu; H J Netter; M Bayer; J Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Assembly of hepatitis delta virus particles.

Authors:  W S Ryu; M Bayer; J Taylor
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates.

Authors:  T B Fu; J Taylor
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity.

Authors:  H N Wu; Y J Lin; F P Lin; S Makino; M F Chang; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  52 in total

1.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs.

Authors:  C E Reid; D W Lazinski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Efficient site-specific nonribozyme opening of hepatitis delta virus genomic RNA in infected livers.

Authors:  J Chang; G Moraleda; S Gudima; J Taylor
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs.

Authors:  Severin O Gudima; Jinhong Chang; John M Taylor
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

7.  Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.

Authors:  Brendan O'Malley; David W Lazinski
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Action of inhibitors on accumulation of processed hepatitis delta virus RNAs.

Authors:  Jinhong Chang; Xingcao Nie; Severin Gudima; John Taylor
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.

Authors:  K S Jeng; A Daniel; M M Lai
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.